315 related articles for article (PubMed ID: 27604840)
1. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.
Chen DC; Du XD; Yin GZ; Yang KB; Nie Y; Wang N; Li YL; Xiu MH; He SC; Yang FD; Cho RY; Kosten TR; Soares JC; Zhao JP; Zhang XY
Psychol Med; 2016 Nov; 46(15):3219-3230. PubMed ID: 27604840
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
[TBL] [Abstract][Full Text] [Related]
3. Glucose disturbances in first-episode drug-naïve schizophrenia: Relationship to psychopathology.
Zhang XY; Chen DC; Tan YL; An HM; Zunta-Soares GB; Huang XF; Soares JC
Psychoneuroendocrinology; 2015 Dec; 62():376-80. PubMed ID: 26385108
[TBL] [Abstract][Full Text] [Related]
4. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.
Ryan MC; Collins P; Thakore JH
Am J Psychiatry; 2003 Feb; 160(2):284-9. PubMed ID: 12562574
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glucose metabolism is associated with clinical symptoms of adolescent-onset patients with first-episode drug-naive schizophrenia.
Hu J; Zhou Y; Wang R; Qi L; Zhou X; Song X; Zeng L; Zhang X
Asian J Psychiatr; 2021 Aug; 62():102716. PubMed ID: 34198180
[TBL] [Abstract][Full Text] [Related]
6. Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?
Sengupta S; Parrilla-Escobar MA; Klink R; Fathalli F; Ying Kin Ng ; Stip E; Baptista T; Malla A; Joober R
Schizophr Res; 2008 Jul; 102(1-3):329-36. PubMed ID: 18396386
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
Shalitin S; Abrahami M; Lilos P; Phillip M
Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
[TBL] [Abstract][Full Text] [Related]
8. The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls.
Wu X; Huang Z; Wu R; Zhong Z; Wei Q; Wang H; Diao F; Wang J; Zheng L; Zhao J; Zhang J
Schizophr Res; 2013 Oct; 150(1):157-62. PubMed ID: 23998954
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical correlates of impaired glucose tolerance in first-episode versus chronic patients with schizophrenia.
Li S; Chen D; Xiu M; Li J; Zhang XY
Early Interv Psychiatry; 2022 Sep; 16(9):985-993. PubMed ID: 34743408
[TBL] [Abstract][Full Text] [Related]
11. Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance.
Bardini G; Dicembrini I; Pala L; Cresci B; Rotella CM
Diabet Med; 2011 Oct; 28(10):1229-33. PubMed ID: 21923697
[TBL] [Abstract][Full Text] [Related]
12. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
[TBL] [Abstract][Full Text] [Related]
13. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
14. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.
Bajraktari G; Koltai MS; Ademaj F; Rexhepaj N; Qirko S; Ndrepepa G; Elezi S
Int J Cardiol; 2006 Jun; 110(2):206-11. PubMed ID: 16297997
[TBL] [Abstract][Full Text] [Related]
15. P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naïve schizophrenia.
Xia L; Wang D; Wei G; Wang J; Zhou H; Xu H; Tian Y; Dai Q; Xiu M; Chen D; Wang L; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110246. PubMed ID: 33453321
[TBL] [Abstract][Full Text] [Related]
16. One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance.
Kleber M; Lass N; Papcke S; Wabitsch M; Reinehr T
Diabet Med; 2010 May; 27(5):516-21. PubMed ID: 20536946
[TBL] [Abstract][Full Text] [Related]
17. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
[TBL] [Abstract][Full Text] [Related]
19. Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia.
Zhang X; Yang M; Du X; Liao W; Chen D; Fan F; Xiu M; Jia Q; Ning Y; Huang X; Wu F; Soares JC; Cao B; Wang L; Chen H
Mol Psychiatry; 2020 Dec; 25(12):3220-3230. PubMed ID: 31409883
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
